Ingenza is worked up to welcome Dr Mark Chadwick to the team as Strategic Business Advisor. Mark will bring extensive industry expertise to his recent position at Ingenza, acquired over 30 years from quite a lot of roles inside small growth corporations, covering the areas of biotechnology, drug discovery and drug development.

Dr Mark Chadwick. Image Credit: Ingenza Ltd.

Mark holds a PhD in Molecular Biology from the University of Newcastle, and an MBA from Imperial College London. Throughout his diverse skilled profession, he has gained priceless experience of constructing each discovery and development businesses, most notably at BioFocus – now a part of Charles River Laboratories – and at pharmaceutical services company Excelsyn. Mark also led the business team at Arcinova for 4 years, achieving a four-fold growth in sales and customer base prior to the corporate’s acquisition by Quotient Sciences.

Ingenza has an illustrious track record of engineering diverse biological systems that help corporations of all sizes to deal with challenges in human health and environmental sustainability. Additionally it is committed to developing green biomanufacturing processes and together, these aspects attracted me to work with the team. I’m very much looking forward to helping Ingenza to drive their growth strategy.”

Dr Mark Chadwick, Strategic Business Advisor​​​​​​​

Mark’s broad skillset will likely be a key resource for us as we seek to turbo charge our recent business development strategy and extend our collaborator network within the pharmaceutical field across discovery, development and manufacturing areas. We’re confident Mark will play a necessary role in helping Ingenza to proceed constructing its international fame as a number one engineering biology company through his in-depth industry insights.”

Jaymin Amin, Chief Business Officer, Ingenza.